Shuwen He,Zhong Lai,Xing Dai,Dong Xiao,Clare London,Nicolas Zorn,Ravi Nargund,Anandan Palani,Casey C. McComas,Peng Li,Xuanjia Peng,Richard Soll
申请号：
US14897966
公开号：
US20160143895A1
申请日:
2014.06.19
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.(I)
